Skip to search formSkip to main contentSkip to account menu

alglucosidase alfa 50 MG Injection [Myozyme]

Known as: ALGLUCOSIDASE ALFA 5 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Myozyme], Myozyme 50 MG Injection 
National Institutes of Health

Related topics

Related topics

9 relations
Alpha-glucosidaseInjectionMannitolMyozyme

Broader (2)

HORMONES/SYNTHETICS/MODIFIERS,OTHERalglucosidase alfa Injection [Myozyme]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Die Chronifizierung von Schmerz verhindern
Der Morbus (M.) Pompe ist durch nächtliche Hypoventilation gekennzeichnet, erklärte Prof. Dr. Peter Young, Schlafmediziner von… 
2017
2017
Ankylosierende Spondylitis
Der Morbus (M.) Pompe ist durch nächtliche Hypoventilation gekennzeichnet, erklärte Prof. Dr. Peter Young, Schlafmediziner von… 
2012
2012
Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study
We examined the efficacy of 2-year enzyme replacement therapy (ERT) using recombinant human α-glucosidase (GAA; Myozyme®) in five… 
2011
2011
Gesundheitsökonomische Aspekte - Replik
Sehr geehrter Herr Kollege, mit grossem Interesse habe ich Ihre medizinische Einschätzung der Problematik der Enzymersatztherapie… 
2011
2011
Alglucosidasa alfa (Myozyme®) per al tractament de pacients amb formes tardanes de la malaltia de Pompe
Malaltia de Pompe; Alglucosidasa alfa; Glicogenosi tipus II; Pompe disease; Alglucosidase alpha; Glycogenosis type II; Enfermedad… 
2007
2007
Nouveautés dans le traitement des myopathies métaboliques
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)